Holdings of the Fund as of 4/24/2025
Total Number of Holdings (excluding cash): 50
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
212 |
$49,074.71 |
2.47% |
| Hoya Corporation |
7741.JP |
J22848105 |
394 |
$45,105.24 |
2.27% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
5,685 |
$43,300.43 |
2.18% |
| Align Technology, Inc. |
ALGN |
016255101 |
232 |
$42,750.64 |
2.15% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
624 |
$42,050.81 |
2.12% |
| ResMed Inc. |
RMD |
761152107 |
177 |
$41,789.70 |
2.10% |
| Penumbra, Inc. |
PEN |
70975L107 |
138 |
$41,158.50 |
2.07% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
545 |
$40,945.85 |
2.06% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,655 |
$40,931.96 |
2.06% |
| The Cooper Companies, Inc. |
COO |
216648501 |
493 |
$40,711.94 |
2.05% |
| Boston Scientific Corporation |
BSX |
101137107 |
401 |
$40,557.14 |
2.04% |
| Danaher Corporation |
DHR |
235851102 |
206 |
$40,479.00 |
2.04% |
| Alcon Inc. |
ALC.SW |
H01301128 |
428 |
$40,405.70 |
2.03% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,997 |
$40,354.57 |
2.03% |
| Baxter International Inc. |
BAX |
071813109 |
1,322 |
$40,202.02 |
2.02% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
766 |
$40,166.33 |
2.02% |
| Waters Corporation |
WAT |
941848103 |
118 |
$40,202.60 |
2.02% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
160 |
$39,958.40 |
2.01% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
597 |
$40,046.76 |
2.01% |
| Masimo Corporation |
MASI |
574795100 |
246 |
$40,006.98 |
2.01% |
| Agilent Technologies, Inc. |
A |
00846U101 |
372 |
$39,811.44 |
2.00% |
| Cochlear Limited |
COH.AU |
Q25953102 |
232 |
$39,667.32 |
2.00% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,122 |
$39,720.12 |
2.00% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
37 |
$39,775.00 |
2.00% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
132 |
$39,808.71 |
2.00% |
| BioMerieux |
BIM.FP |
F1149Y232 |
303 |
$39,527.01 |
1.99% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
321 |
$39,563.76 |
1.99% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
360 |
$39,335.71 |
1.98% |
| DexCom, Inc. |
DXCM |
252131107 |
553 |
$39,141.34 |
1.97% |
| Teleflex Incorporated |
TFX |
879369106 |
288 |
$39,070.08 |
1.97% |
| Abbott Laboratories |
ABT |
002824100 |
299 |
$38,684.62 |
1.95% |
| Exact Sciences Corporation |
EXAS |
30063P105 |
850 |
$38,760.00 |
1.95% |
| Steris Plc |
STE |
G8473T100 |
171 |
$38,705.85 |
1.95% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
76 |
$38,617.88 |
1.94% |
| Stryker Corporation |
SYK |
863667101 |
107 |
$38,632.35 |
1.94% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
183 |
$38,537.97 |
1.94% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
524 |
$38,288.68 |
1.93% |
| Insulet Corporation |
PODD |
45784P101 |
148 |
$38,388.24 |
1.93% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
406 |
$38,436.02 |
1.93% |
| Becton, Dickinson and Company |
BDX |
075887109 |
187 |
$38,232.15 |
1.92% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,881 |
$37,913.25 |
1.91% |
| Hologic, Inc. |
HOLX |
436440101 |
651 |
$37,946.79 |
1.91% |
| Medtronic Plc |
MDT |
G5960L103 |
451 |
$38,019.30 |
1.91% |
| Revvity, Inc. |
RVTY |
714046109 |
400 |
$38,052.00 |
1.91% |
| Olympus Corporation |
7733.JP |
J61240107 |
2,940 |
$37,512.10 |
1.89% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
87 |
$37,119.42 |
1.87% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
364 |
$36,946.00 |
1.86% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
1,873 |
$36,546.11 |
1.84% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
1,934 |
$36,296.07 |
1.83% |
| Terumo Corporation |
4543.JP |
J83173104 |
1,860 |
$35,640.51 |
1.79% |
| US Dollar |
$USD |
|
5,003 |
$5,002.85 |
0.25% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|